IDENTIFICATION OF SURFACE-ASSOCIATED ANTIGENS FOR TUMOR DIAGNOSIS AND THERAPY

Title:

IDENTIFICATION OF SURFACE-ASSOCIATED ANTIGENS FOR TUMOR DIAGNOSIS AND THERAPY

Document Type and Number:

Japanese Patent JP2012207020

Kind Code:

A

Abstract:

To provide a pharmaceutical composition containing an agent that inhibits expression or activity of a tumor-associated antigen.

The pharmaceutical composition contains one or more components selected from the group consisting of: (i) a specific tumor-associated antigen or a part thereof; (ii) a nucleic acid which codes for a specific tumor-associated antigen or for a part thereof; (iii) an antibody which binds to a specific tumor-associated antigen or to a part thereof; (iv) an antisense nucleic acid which specifically hybridizes with a nucleic acid coding for a specific tumor-associated antigen; (v) a host cell which expresses a specific tumor-associated antigen or a part thereof; and (vi) isolated complexes between a specific tumor-associated antigen or a part thereof and an HLA molecule.

More Like This:

JP2022526127	Extracellular vesicles for vaccine delivery
JPWO2020027200	Cartilage-related disease therapeutic agent
JP2021501601	Cornulin (CRNN) variant and its use

Inventors:

SAHIN UGUR
TUERECI OEZLEM
KOSLOWSKI MICHAEL
HELFTENBEIN GERD
USENER DIRK
SCHLUETER VOLKER

Application Number:

JP2012083549A

Publication Date:

October 25, 2012

Filing Date:

April 02, 2012

Export Citation:

Click for automatic bibliography generation Help

Assignee:

GANYMED PHARMACEUTICALS AG

International Classes:

A61K45/00; A61K31/7088; A61K31/7105; A61K35/12; A61K39/39; A61K39/395; A61K48/00; A61K49/00; A61P35/00; A61P35/04; C07K16/30; C07K16/46; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/09; C12N15/113; C12Q1/68; G01N33/574; G16B30/10; C12P21/08

Domestic Patent References:

JP2002514073A	2002-05-14
JP2002512524A	2002-04-23
JP2002539767A	2002-11-26
JP2002512524A	2002-04-23
JP2002539767A	2002-11-26
JP2002514073A	2002-05-14

Foreign References:

WO2003076631A2	2003-09-18
WO2003076631A2	2003-09-18

Other References:

JPN6011063851; Ｐｒｏｔｅｏｍｉｃｓ，　１［１０］　（２００１）　ｐ．１２６４-１２７０
JPN6011063848; Ｂｉｏｔｈｅｒａｐｙ，　１６［５］　（２００２）　ｐ．４４１-４４８
JPN6011063846; Ｂｉｏｔｈｅｒａｐｙ，　１８［６］　（２００４）　ｐ．４９７-５０２
JPN6011063851; Ｐｒｏｔｅｏｍｉｃｓ，　１［１０］　（２００１）　ｐ．１２６４-１２７０
JPN6011063848; Ｂｉｏｔｈｅｒａｐｙ，　１６［５］　（２００２）　ｐ．４４１-４４８
JPN6011063846; Ｂｉｏｔｈｅｒａｐｙ，　１８［６］　（２００４）　ｐ．４９７-５０２

Attorney, Agent or Firm:

Takashi Shoji

Previous Patent: CONCENTRATED LIQUID HAIR CLEANING AGENT COMPOSITION

Next Patent: 1,2-DIHYDROPYRIDINE COMPOUND, METHOD FOR PRODUCING THE SAME AND USE THEREOF